nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Gemcitabine—urinary bladder cancer	0.147	0.215	CbGbCtD
Tenofovir—ABCC10—Etoposide—urinary bladder cancer	0.105	0.154	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—urinary bladder cancer	0.0714	0.105	CbGbCtD
Tenofovir—ABCC10—Methotrexate—urinary bladder cancer	0.0692	0.102	CbGbCtD
Tenofovir—ABCC4—Fluorouracil—urinary bladder cancer	0.0603	0.0884	CbGbCtD
Tenofovir—ABCC2—Carboplatin—urinary bladder cancer	0.0356	0.0523	CbGbCtD
Tenofovir—ABCC4—Methotrexate—urinary bladder cancer	0.0332	0.0488	CbGbCtD
Tenofovir—ABCC2—Cisplatin—urinary bladder cancer	0.0305	0.0447	CbGbCtD
Tenofovir—ABCC2—Etoposide—urinary bladder cancer	0.0299	0.0439	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—urinary bladder cancer	0.0208	0.0305	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—urinary bladder cancer	0.0204	0.0299	CbGbCtD
Tenofovir—ABCC2—Methotrexate—urinary bladder cancer	0.0198	0.029	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—urinary bladder cancer	0.0145	0.0212	CbGbCtD
Tenofovir—CYP1A2—Fluorouracil—urinary bladder cancer	0.0134	0.0196	CbGbCtD
Tenofovir—CYP1A2—Etoposide—urinary bladder cancer	0.0112	0.0164	CbGbCtD
Tenofovir—Cidofovir—TYMP—urinary bladder cancer	0.00735	0.922	CrCbGaD
Tenofovir—AK2—prostate gland—urinary bladder cancer	0.00549	0.0638	CbGeAlD
Tenofovir—SLC22A8—urine—urinary bladder cancer	0.00442	0.0513	CbGeAlD
Tenofovir—NME1—prostate gland—urinary bladder cancer	0.00421	0.0489	CbGeAlD
Tenofovir—AK4—prostate gland—urinary bladder cancer	0.00406	0.0472	CbGeAlD
Tenofovir—NME2—prostate gland—urinary bladder cancer	0.00397	0.0461	CbGeAlD
Tenofovir—NME1-NME2—female reproductive system—urinary bladder cancer	0.00395	0.0459	CbGeAlD
Tenofovir—AK4—seminal vesicle—urinary bladder cancer	0.00343	0.0399	CbGeAlD
Tenofovir—CYP1A2—urine—urinary bladder cancer	0.00302	0.0351	CbGeAlD
Tenofovir—NME2—epithelium—urinary bladder cancer	0.00292	0.0339	CbGeAlD
Tenofovir—NME1—renal system—urinary bladder cancer	0.00287	0.0334	CbGeAlD
Tenofovir—AK4—renal system—urinary bladder cancer	0.00277	0.0321	CbGeAlD
Tenofovir—AK4—urethra—urinary bladder cancer	0.00272	0.0316	CbGeAlD
Tenofovir—AK2—vagina—urinary bladder cancer	0.00271	0.0315	CbGeAlD
Tenofovir—NME2—renal system—urinary bladder cancer	0.00271	0.0314	CbGeAlD
Tenofovir—NME1-NME2—lymph node—urinary bladder cancer	0.00231	0.0269	CbGeAlD
Tenofovir—NME1—female reproductive system—urinary bladder cancer	0.0023	0.0267	CbGeAlD
Tenofovir—AK4—female reproductive system—urinary bladder cancer	0.00222	0.0257	CbGeAlD
Tenofovir—NME2—female reproductive system—urinary bladder cancer	0.00217	0.0252	CbGeAlD
Tenofovir—AK4—vagina—urinary bladder cancer	0.002	0.0233	CbGeAlD
Tenofovir—ABCC10—prostate gland—urinary bladder cancer	0.00193	0.0224	CbGeAlD
Tenofovir—AK2—lymph node—urinary bladder cancer	0.00175	0.0204	CbGeAlD
Tenofovir—ABCC10—seminal vesicle—urinary bladder cancer	0.00163	0.0189	CbGeAlD
Tenofovir—ABCC4—prostate gland—urinary bladder cancer	0.0016	0.0186	CbGeAlD
Tenofovir—SLC22A8—prostate gland—urinary bladder cancer	0.00159	0.0184	CbGeAlD
Tenofovir—ABCC2—prostate gland—urinary bladder cancer	0.00155	0.018	CbGeAlD
Tenofovir—NME1—lymph node—urinary bladder cancer	0.00135	0.0156	CbGeAlD
Tenofovir—ABCC10—renal system—urinary bladder cancer	0.00131	0.0152	CbGeAlD
Tenofovir—AK4—lymph node—urinary bladder cancer	0.0013	0.0151	CbGeAlD
Tenofovir—ABCC10—urethra—urinary bladder cancer	0.00129	0.015	CbGeAlD
Tenofovir—NME2—lymph node—urinary bladder cancer	0.00127	0.0147	CbGeAlD
Tenofovir—ABCC4—renal system—urinary bladder cancer	0.00109	0.0126	CbGeAlD
Tenofovir—SLC22A8—renal system—urinary bladder cancer	0.00108	0.0125	CbGeAlD
Tenofovir—ABCC2—renal system—urinary bladder cancer	0.00105	0.0122	CbGeAlD
Tenofovir—ABCC10—female reproductive system—urinary bladder cancer	0.00105	0.0122	CbGeAlD
Tenofovir—ABCC10—vagina—urinary bladder cancer	0.000951	0.011	CbGeAlD
Tenofovir—ABCC4—female reproductive system—urinary bladder cancer	0.000872	0.0101	CbGeAlD
Tenofovir—ABCC2—female reproductive system—urinary bladder cancer	0.000844	0.00981	CbGeAlD
Tenofovir—CYP1A2—renal system—urinary bladder cancer	0.00074	0.00859	CbGeAlD
Tenofovir—Adenosine monophosphate—SRC—urinary bladder cancer	0.00062	0.0777	CrCbGaD
Tenofovir—ABCC10—lymph node—urinary bladder cancer	0.000615	0.00714	CbGeAlD
Tenofovir—ABCC4—lymph node—urinary bladder cancer	0.00051	0.00593	CbGeAlD
Tenofovir—ABCC2—lymph node—urinary bladder cancer	0.000494	0.00574	CbGeAlD
Tenofovir—AK2—Metabolism—GSTO2—urinary bladder cancer	0.000391	0.00386	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NAT1—urinary bladder cancer	0.000391	0.00386	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000387	0.00382	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—EP300—urinary bladder cancer	0.000375	0.00369	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—urinary bladder cancer	0.000361	0.00356	CbGpPWpGaD
Tenofovir—AK2—Metabolism—UGT2B7—urinary bladder cancer	0.000358	0.00353	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000337	0.00332	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MYC—urinary bladder cancer	0.000327	0.00322	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000326	0.00321	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP4B1—urinary bladder cancer	0.000322	0.00317	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000315	0.0031	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000308	0.00304	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.000306	0.00301	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SLC19A1—urinary bladder cancer	0.000304	0.003	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000302	0.00298	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MMP9—urinary bladder cancer	0.0003	0.00295	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PRSS3—urinary bladder cancer	0.000296	0.00292	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—urinary bladder cancer	0.00029	0.00285	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTZ1—urinary bladder cancer	0.000286	0.00282	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—EP300—urinary bladder cancer	0.000284	0.0028	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000281	0.00277	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000272	0.00268	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTO2—urinary bladder cancer	0.000271	0.00267	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NAT1—urinary bladder cancer	0.000271	0.00267	CbGpPWpGaD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000269	0.00265	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000269	0.00265	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—urinary bladder cancer	0.000268	0.00264	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000268	0.00264	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000266	0.00262	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000257	0.00253	CbGpPWpGaD
Tenofovir—NME2—Metabolism—UGT2B7—urinary bladder cancer	0.000248	0.00244	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MYC—urinary bladder cancer	0.000247	0.00244	CbGpPWpGaD
Tenofovir—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000244	0.00198	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.000243	0.0024	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.000243	0.0024	CbGpPWpGaD
Tenofovir—Anorexia—Gemcitabine—urinary bladder cancer	0.000241	0.00196	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—urinary bladder cancer	0.000239	0.00195	CcSEcCtD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.000239	0.00235	CbGpPWpGaD
Tenofovir—Body temperature increased—Thiotepa—urinary bladder cancer	0.000238	0.00193	CcSEcCtD
Tenofovir—Abdominal pain—Thiotepa—urinary bladder cancer	0.000238	0.00193	CcSEcCtD
Tenofovir—Anorexia—Fluorouracil—urinary bladder cancer	0.000237	0.00193	CcSEcCtD
Tenofovir—AK2—Metabolism—TYMP—urinary bladder cancer	0.000237	0.00234	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000237	0.00233	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000236	0.00232	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000235	0.00231	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000234	0.00231	CbGpPWpGaD
Tenofovir—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000231	0.00188	CcSEcCtD
Tenofovir—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000231	0.00188	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00023	0.00187	CcSEcCtD
Tenofovir—Skin disorder—Cisplatin—urinary bladder cancer	0.000229	0.00186	CcSEcCtD
Tenofovir—Insomnia—Gemcitabine—urinary bladder cancer	0.000229	0.00186	CcSEcCtD
Tenofovir—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000228	0.00185	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000227	0.00184	CcSEcCtD
Tenofovir—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000225	0.00183	CcSEcCtD
Tenofovir—Chest pain—Etoposide—urinary bladder cancer	0.000225	0.00183	CcSEcCtD
Tenofovir—Insomnia—Fluorouracil—urinary bladder cancer	0.000225	0.00183	CcSEcCtD
Tenofovir—Anorexia—Cisplatin—urinary bladder cancer	0.000225	0.00183	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000224	0.00182	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000224	0.00182	CcSEcCtD
Tenofovir—NME2—Metabolism—CYP4B1—urinary bladder cancer	0.000223	0.0022	CbGpPWpGaD
Tenofovir—Pancreatitis—Methotrexate—urinary bladder cancer	0.000223	0.00181	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.000222	0.00219	CbGpPWpGaD
Tenofovir—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000222	0.0018	CcSEcCtD
Tenofovir—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000222	0.0018	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000221	0.00217	CbGpPWpGaD
Tenofovir—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00022	0.00179	CcSEcCtD
Tenofovir—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00022	0.00179	CcSEcCtD
Tenofovir—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000219	0.00178	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000218	0.00178	CcSEcCtD
Tenofovir—Fatigue—Gemcitabine—urinary bladder cancer	0.000218	0.00177	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—urinary bladder cancer	0.000217	0.00177	CcSEcCtD
Tenofovir—NME1—Metabolism—GSTZ1—urinary bladder cancer	0.000217	0.00214	CbGpPWpGaD
Tenofovir—Pain—Gemcitabine—urinary bladder cancer	0.000216	0.00176	CcSEcCtD
Tenofovir—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000216	0.00176	CcSEcCtD
Tenofovir—Asthenia—Thiotepa—urinary bladder cancer	0.000216	0.00175	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000215	0.00175	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000215	0.00175	CcSEcCtD
Tenofovir—AK2—Metabolism—NAT2—urinary bladder cancer	0.000214	0.00211	CbGpPWpGaD
Tenofovir—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000214	0.00174	CcSEcCtD
Tenofovir—Pruritus—Thiotepa—urinary bladder cancer	0.000213	0.00173	CcSEcCtD
Tenofovir—Pain—Fluorouracil—urinary bladder cancer	0.000213	0.00173	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000211	0.00172	CcSEcCtD
Tenofovir—NME2—Metabolism—SLC19A1—urinary bladder cancer	0.000211	0.00208	CbGpPWpGaD
Tenofovir—Dyspnoea—Cisplatin—urinary bladder cancer	0.00021	0.00171	CcSEcCtD
Tenofovir—Skin disorder—Etoposide—urinary bladder cancer	0.00021	0.00171	CcSEcCtD
Tenofovir—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000209	0.0017	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—urinary bladder cancer	0.000209	0.0017	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000207	0.00169	CcSEcCtD
Tenofovir—Anorexia—Etoposide—urinary bladder cancer	0.000206	0.00167	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000206	0.00203	CbGpPWpGaD
Tenofovir—Diarrhoea—Thiotepa—urinary bladder cancer	0.000206	0.00167	CcSEcCtD
Tenofovir—NME2—Metabolism—PRSS3—urinary bladder cancer	0.000205	0.00203	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTO2—urinary bladder cancer	0.000205	0.00203	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NAT1—urinary bladder cancer	0.000205	0.00203	CbGpPWpGaD
Tenofovir—Decreased appetite—Cisplatin—urinary bladder cancer	0.000205	0.00167	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—urinary bladder cancer	0.000204	0.00166	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000204	0.00166	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000204	0.00165	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—urinary bladder cancer	0.000203	0.002	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000203	0.002	CbGpPWpGaD
Tenofovir—Infestation—Methotrexate—urinary bladder cancer	0.000203	0.00165	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—urinary bladder cancer	0.000203	0.00165	CcSEcCtD
Tenofovir—Depression—Methotrexate—urinary bladder cancer	0.000202	0.00164	CcSEcCtD
Tenofovir—Pain—Cisplatin—urinary bladder cancer	0.000202	0.00164	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000201	0.00163	CcSEcCtD
Tenofovir—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0002	0.00163	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—urinary bladder cancer	0.000199	0.00162	CcSEcCtD
Tenofovir—Dizziness—Thiotepa—urinary bladder cancer	0.000199	0.00162	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000198	0.00161	CcSEcCtD
Tenofovir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000197	0.0016	CcSEcCtD
Tenofovir—Sweating—Methotrexate—urinary bladder cancer	0.000194	0.00158	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—urinary bladder cancer	0.000193	0.00157	CcSEcCtD
Tenofovir—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000193	0.00157	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—urinary bladder cancer	0.000193	0.00157	CcSEcCtD
Tenofovir—Dyspnoea—Etoposide—urinary bladder cancer	0.000193	0.00157	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000192	0.00156	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000192	0.00156	CcSEcCtD
Tenofovir—Vomiting—Thiotepa—urinary bladder cancer	0.000191	0.00155	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—urinary bladder cancer	0.000191	0.00155	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—urinary bladder cancer	0.00019	0.00154	CcSEcCtD
Tenofovir—Infestation—Epirubicin—urinary bladder cancer	0.00019	0.00154	CcSEcCtD
Tenofovir—Rash—Thiotepa—urinary bladder cancer	0.00019	0.00154	CcSEcCtD
Tenofovir—Dermatitis—Thiotepa—urinary bladder cancer	0.000189	0.00154	CcSEcCtD
Tenofovir—Headache—Thiotepa—urinary bladder cancer	0.000188	0.00153	CcSEcCtD
Tenofovir—NME1—Metabolism—UGT2B7—urinary bladder cancer	0.000188	0.00185	CbGpPWpGaD
Tenofovir—Decreased appetite—Etoposide—urinary bladder cancer	0.000188	0.00153	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—urinary bladder cancer	0.000187	0.00152	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000186	0.00152	CcSEcCtD
Tenofovir—Body temperature increased—Cisplatin—urinary bladder cancer	0.000186	0.00152	CcSEcCtD
Tenofovir—Fatigue—Etoposide—urinary bladder cancer	0.000186	0.00151	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000186	0.00151	CcSEcCtD
Tenofovir—AK2—Metabolism—RRM2—urinary bladder cancer	0.000185	0.00182	CbGpPWpGaD
Tenofovir—Pain—Etoposide—urinary bladder cancer	0.000185	0.0015	CcSEcCtD
Tenofovir—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000183	0.00149	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000183	0.00149	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—urinary bladder cancer	0.000182	0.00148	CcSEcCtD
Tenofovir—Sweating—Epirubicin—urinary bladder cancer	0.000182	0.00148	CcSEcCtD
Tenofovir—Asthenia—Gemcitabine—urinary bladder cancer	0.000181	0.00148	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—NQO1—urinary bladder cancer	0.000181	0.00178	CbGpPWpGaD
Tenofovir—Haematuria—Epirubicin—urinary bladder cancer	0.000181	0.00147	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00018	0.00146	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00018	0.00146	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000179	0.00177	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000179	0.00176	CbGpPWpGaD
Tenofovir—Pruritus—Gemcitabine—urinary bladder cancer	0.000179	0.00145	CcSEcCtD
Tenofovir—Nausea—Thiotepa—urinary bladder cancer	0.000179	0.00145	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—urinary bladder cancer	0.000178	0.00145	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—urinary bladder cancer	0.000178	0.00145	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—urinary bladder cancer	0.000178	0.00145	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000178	0.00144	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—urinary bladder cancer	0.000177	0.00144	CcSEcCtD
Tenofovir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000177	0.00144	CcSEcCtD
Tenofovir—Pruritus—Fluorouracil—urinary bladder cancer	0.000176	0.00143	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000176	0.00143	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—urinary bladder cancer	0.000176	0.00143	CcSEcCtD
Tenofovir—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000174	0.00141	CcSEcCtD
Tenofovir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000173	0.00141	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—urinary bladder cancer	0.000173	0.0014	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000172	0.0017	CbGpPWpGaD
Tenofovir—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000172	0.0014	CcSEcCtD
Tenofovir—AK2—Metabolism—HPGDS—urinary bladder cancer	0.000171	0.00169	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ENO2—urinary bladder cancer	0.000171	0.00169	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000171	0.00169	CbGpPWpGaD
Tenofovir—Abdominal pain—Etoposide—urinary bladder cancer	0.000171	0.00139	CcSEcCtD
Tenofovir—Body temperature increased—Etoposide—urinary bladder cancer	0.000171	0.00139	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—urinary bladder cancer	0.00017	0.00139	CcSEcCtD
Tenofovir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00017	0.00138	CcSEcCtD
Tenofovir—NME1—Metabolism—CYP4B1—urinary bladder cancer	0.000169	0.00167	CbGpPWpGaD
Tenofovir—Asthenia—Cisplatin—urinary bladder cancer	0.000169	0.00138	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000169	0.00166	CbGpPWpGaD
Tenofovir—Sweating—Doxorubicin—urinary bladder cancer	0.000168	0.00137	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000168	0.00137	CcSEcCtD
Tenofovir—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000167	0.00165	CbGpPWpGaD
Tenofovir—Haematuria—Doxorubicin—urinary bladder cancer	0.000167	0.00136	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000167	0.00136	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—urinary bladder cancer	0.000167	0.00136	CcSEcCtD
Tenofovir—AK2—Metabolism—GSTT1—urinary bladder cancer	0.000166	0.00164	CbGpPWpGaD
Tenofovir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000166	0.00135	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—urinary bladder cancer	0.000165	0.00134	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—urinary bladder cancer	0.000164	0.00134	CcSEcCtD
Tenofovir—Dizziness—Fluorouracil—urinary bladder cancer	0.000164	0.00134	CcSEcCtD
Tenofovir—NME2—Metabolism—TYMP—urinary bladder cancer	0.000164	0.00162	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000164	0.00162	CbGpPWpGaD
Tenofovir—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000164	0.00133	CcSEcCtD
Tenofovir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000161	0.00131	CcSEcCtD
Tenofovir—Vomiting—Gemcitabine—urinary bladder cancer	0.000161	0.00131	CcSEcCtD
Tenofovir—NME1—Metabolism—SLC19A1—urinary bladder cancer	0.00016	0.00157	CbGpPWpGaD
Tenofovir—Mental disorder—Methotrexate—urinary bladder cancer	0.00016	0.0013	CcSEcCtD
Tenofovir—Rash—Gemcitabine—urinary bladder cancer	0.000159	0.0013	CcSEcCtD
Tenofovir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000159	0.0013	CcSEcCtD
Tenofovir—Hypersensitivity—Etoposide—urinary bladder cancer	0.000159	0.00129	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—urinary bladder cancer	0.000158	0.00129	CcSEcCtD
Tenofovir—Headache—Gemcitabine—urinary bladder cancer	0.000158	0.00129	CcSEcCtD
Tenofovir—Vomiting—Fluorouracil—urinary bladder cancer	0.000158	0.00129	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000158	0.00128	CcSEcCtD
Tenofovir—Rash—Fluorouracil—urinary bladder cancer	0.000157	0.00127	CcSEcCtD
Tenofovir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000157	0.00127	CcSEcCtD
Tenofovir—Headache—Fluorouracil—urinary bladder cancer	0.000156	0.00127	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000156	0.00127	CcSEcCtD
Tenofovir—NME1—Metabolism—PRSS3—urinary bladder cancer	0.000156	0.00153	CbGpPWpGaD
Tenofovir—Asthenia—Etoposide—urinary bladder cancer	0.000155	0.00126	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000155	0.00126	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000155	0.00126	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—urinary bladder cancer	0.000154	0.00125	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000154	0.00125	CcSEcCtD
Tenofovir—Back pain—Methotrexate—urinary bladder cancer	0.000153	0.00125	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000153	0.00151	CbGpPWpGaD
Tenofovir—Pruritus—Etoposide—urinary bladder cancer	0.000153	0.00124	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—NQO1—urinary bladder cancer	0.000153	0.0015	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—IGF1—urinary bladder cancer	0.000153	0.0015	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000152	0.0015	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—GSTP1—urinary bladder cancer	0.000151	0.00149	CbGpPWpGaD
Tenofovir—Nausea—Gemcitabine—urinary bladder cancer	0.00015	0.00122	CcSEcCtD
Tenofovir—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.00015	0.00148	CbGpPWpGaD
Tenofovir—Vomiting—Cisplatin—urinary bladder cancer	0.00015	0.00122	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—urinary bladder cancer	0.000149	0.00121	CcSEcCtD
Tenofovir—Rash—Cisplatin—urinary bladder cancer	0.000149	0.00121	CcSEcCtD
Tenofovir—NME2—Metabolism—NAT2—urinary bladder cancer	0.000149	0.00146	CbGpPWpGaD
Tenofovir—Dermatitis—Cisplatin—urinary bladder cancer	0.000148	0.00121	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—urinary bladder cancer	0.000148	0.00121	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000148	0.00146	CbGpPWpGaD
Tenofovir—Diarrhoea—Etoposide—urinary bladder cancer	0.000148	0.0012	CcSEcCtD
Tenofovir—Nausea—Fluorouracil—urinary bladder cancer	0.000148	0.0012	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000147	0.00145	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000147	0.00145	CbGpPWpGaD
Tenofovir—Flatulence—Epirubicin—urinary bladder cancer	0.000146	0.00119	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000145	0.00143	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000144	0.00142	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000144	0.00142	CbGpPWpGaD
Tenofovir—Back pain—Epirubicin—urinary bladder cancer	0.000143	0.00117	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000143	0.00141	CbGpPWpGaD
Tenofovir—Dizziness—Etoposide—urinary bladder cancer	0.000143	0.00116	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000142	0.00116	CcSEcCtD
Tenofovir—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000142	0.0014	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000142	0.0014	CbGpPWpGaD
Tenofovir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000142	0.00116	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00014	0.00138	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.00014	0.00138	CbGpPWpGaD
Tenofovir—Nausea—Cisplatin—urinary bladder cancer	0.00014	0.00114	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—GSTM1—urinary bladder cancer	0.000139	0.00137	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000138	0.00136	CbGpPWpGaD
Tenofovir—Mental disorder—Doxorubicin—urinary bladder cancer	0.000138	0.00112	CcSEcCtD
Tenofovir—AK2—Metabolism—NQO1—urinary bladder cancer	0.000138	0.00136	CbGpPWpGaD
Tenofovir—Vomiting—Etoposide—urinary bladder cancer	0.000137	0.00112	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000137	0.00112	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000136	0.00134	CbGpPWpGaD
Tenofovir—Rash—Etoposide—urinary bladder cancer	0.000136	0.00111	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—urinary bladder cancer	0.000136	0.00111	CcSEcCtD
Tenofovir—Headache—Etoposide—urinary bladder cancer	0.000135	0.0011	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—urinary bladder cancer	0.000135	0.0011	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—urinary bladder cancer	0.000135	0.0011	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—urinary bladder cancer	0.000135	0.0011	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—urinary bladder cancer	0.000135	0.0011	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000134	0.00109	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000133	0.00131	CbGpPWpGaD
Tenofovir—Back pain—Doxorubicin—urinary bladder cancer	0.000133	0.00108	CcSEcCtD
Tenofovir—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.00013	0.00128	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000128	0.00127	CbGpPWpGaD
Tenofovir—Nausea—Etoposide—urinary bladder cancer	0.000128	0.00104	CcSEcCtD
Tenofovir—NME2—Metabolism—RRM2—urinary bladder cancer	0.000128	0.00126	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—GSTP1—urinary bladder cancer	0.000127	0.00125	CbGpPWpGaD
Tenofovir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000127	0.00103	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—urinary bladder cancer	0.000126	0.00103	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—urinary bladder cancer	0.000126	0.00103	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—urinary bladder cancer	0.000126	0.00103	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—urinary bladder cancer	0.000126	0.00102	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—urinary bladder cancer	0.000126	0.00102	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000125	0.00102	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000125	0.00102	CcSEcCtD
Tenofovir—NME1—Metabolism—TYMP—urinary bladder cancer	0.000124	0.00123	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000124	0.00122	CbGpPWpGaD
Tenofovir—Anorexia—Methotrexate—urinary bladder cancer	0.000123	0.001	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000122	0.0012	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000119	0.00118	CbGpPWpGaD
Tenofovir—NME2—Metabolism—HPGDS—urinary bladder cancer	0.000119	0.00117	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ENO2—urinary bladder cancer	0.000119	0.00117	CbGpPWpGaD
Tenofovir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000119	0.000965	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000119	0.00117	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000118	0.000958	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—urinary bladder cancer	0.000118	0.000956	CcSEcCtD
Tenofovir—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000117	0.00116	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000117	0.000951	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—urinary bladder cancer	0.000117	0.000951	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—GSTM1—urinary bladder cancer	0.000117	0.00115	CbGpPWpGaD
Tenofovir—Arthralgia—Doxorubicin—urinary bladder cancer	0.000117	0.00095	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—urinary bladder cancer	0.000117	0.00095	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—urinary bladder cancer	0.000117	0.00095	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—urinary bladder cancer	0.000116	0.000947	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000116	0.000943	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000116	0.00114	CbGpPWpGaD
Tenofovir—Anorexia—Epirubicin—urinary bladder cancer	0.000115	0.000938	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—urinary bladder cancer	0.000115	0.000938	CcSEcCtD
Tenofovir—NME2—Metabolism—GSTT1—urinary bladder cancer	0.000115	0.00114	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTP1—urinary bladder cancer	0.000115	0.00114	CbGpPWpGaD
Tenofovir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000114	0.000926	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000114	0.00112	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000113	0.00111	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NAT2—urinary bladder cancer	0.000113	0.00111	CbGpPWpGaD
Tenofovir—Decreased appetite—Methotrexate—urinary bladder cancer	0.000112	0.000914	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000112	0.000908	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—urinary bladder cancer	0.000112	0.000907	CcSEcCtD
Tenofovir—Pain—Methotrexate—urinary bladder cancer	0.000111	0.000899	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00011	0.000897	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00011	0.000893	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—urinary bladder cancer	0.000109	0.00089	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000885	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000108	0.00088	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—urinary bladder cancer	0.000108	0.000877	CcSEcCtD
Tenofovir—AK2—Metabolism—TYMS—urinary bladder cancer	0.000107	0.00106	CbGpPWpGaD
Tenofovir—Anorexia—Doxorubicin—urinary bladder cancer	0.000107	0.000868	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000107	0.000866	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000107	0.00105	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTM1—urinary bladder cancer	0.000106	0.00104	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NCOR1—urinary bladder cancer	0.000106	0.00104	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000106	0.00086	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—urinary bladder cancer	0.000105	0.000856	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000105	0.00085	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—urinary bladder cancer	0.000104	0.000849	CcSEcCtD
Tenofovir—Pain—Epirubicin—urinary bladder cancer	0.000104	0.000842	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000103	0.00102	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000103	0.00102	CbGpPWpGaD
Tenofovir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000102	0.000831	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000102	0.000831	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000102	0.00083	CcSEcCtD
Tenofovir—AK2—Metabolism—GPX1—urinary bladder cancer	0.000101	0.000999	CbGpPWpGaD
Tenofovir—Insomnia—Doxorubicin—urinary bladder cancer	0.000101	0.000824	CcSEcCtD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000101	0.000995	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000101	0.000995	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.0001	0.000989	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.0001	0.000987	CbGpPWpGaD
Tenofovir—Dyspnoea—Doxorubicin—urinary bladder cancer	9.99e-05	0.000812	CcSEcCtD
Tenofovir—AK2—Metabolism—ERCC2—urinary bladder cancer	9.95e-05	0.000981	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	9.91e-05	0.000977	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	9.9e-05	0.000805	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—urinary bladder cancer	9.86e-05	0.000802	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—urinary bladder cancer	9.74e-05	0.000792	CcSEcCtD
Tenofovir—NME1—Metabolism—RRM2—urinary bladder cancer	9.72e-05	0.000958	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.67e-05	0.000954	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	9.67e-05	0.000786	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—urinary bladder cancer	9.66e-05	0.000785	CcSEcCtD
Tenofovir—Pain—Doxorubicin—urinary bladder cancer	9.58e-05	0.000779	CcSEcCtD
Tenofovir—NME2—Metabolism—NQO1—urinary bladder cancer	9.57e-05	0.000943	CbGpPWpGaD
Tenofovir—Body temperature increased—Epirubicin—urinary bladder cancer	9.57e-05	0.000778	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—urinary bladder cancer	9.57e-05	0.000778	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—urinary bladder cancer	9.53e-05	0.000775	CcSEcCtD
Tenofovir—AK2—Metabolism—MTHFR—urinary bladder cancer	9.35e-05	0.000922	CbGpPWpGaD
Tenofovir—Asthenia—Methotrexate—urinary bladder cancer	9.28e-05	0.000755	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.16e-05	0.000745	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—urinary bladder cancer	9.15e-05	0.000744	CcSEcCtD
Tenofovir—NME1—Metabolism—ENO2—urinary bladder cancer	9e-05	0.000887	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HPGDS—urinary bladder cancer	9e-05	0.000887	CbGpPWpGaD
Tenofovir—Hypersensitivity—Epirubicin—urinary bladder cancer	8.92e-05	0.000725	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—urinary bladder cancer	8.85e-05	0.00072	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—urinary bladder cancer	8.85e-05	0.00072	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—urinary bladder cancer	8.85e-05	0.00072	CcSEcCtD
Tenofovir—NME1—Metabolism—GSTT1—urinary bladder cancer	8.73e-05	0.00086	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	8.69e-05	0.000857	CbGpPWpGaD
Tenofovir—Asthenia—Epirubicin—urinary bladder cancer	8.69e-05	0.000706	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—urinary bladder cancer	8.56e-05	0.000696	CcSEcCtD
Tenofovir—Dizziness—Methotrexate—urinary bladder cancer	8.55e-05	0.000695	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.42e-05	0.00083	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.4e-05	0.000828	CbGpPWpGaD
Tenofovir—Diarrhoea—Epirubicin—urinary bladder cancer	8.28e-05	0.000673	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.25e-05	0.000671	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—urinary bladder cancer	8.22e-05	0.000669	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.16e-05	0.000804	CbGpPWpGaD
Tenofovir—Rash—Methotrexate—urinary bladder cancer	8.16e-05	0.000663	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—urinary bladder cancer	8.15e-05	0.000662	CcSEcCtD
Tenofovir—Headache—Methotrexate—urinary bladder cancer	8.1e-05	0.000659	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—urinary bladder cancer	8.04e-05	0.000653	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—urinary bladder cancer	8.01e-05	0.000651	CcSEcCtD
Tenofovir—NME2—Metabolism—GSTP1—urinary bladder cancer	7.98e-05	0.000787	CbGpPWpGaD
Tenofovir—Pruritus—Doxorubicin—urinary bladder cancer	7.92e-05	0.000644	CcSEcCtD
Tenofovir—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	7.8e-05	0.000769	CbGpPWpGaD
Tenofovir—Vomiting—Epirubicin—urinary bladder cancer	7.7e-05	0.000626	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	7.69e-05	0.000758	CbGpPWpGaD
Tenofovir—Nausea—Methotrexate—urinary bladder cancer	7.68e-05	0.000625	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—urinary bladder cancer	7.66e-05	0.000623	CcSEcCtD
Tenofovir—Rash—Epirubicin—urinary bladder cancer	7.63e-05	0.000621	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—urinary bladder cancer	7.63e-05	0.00062	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	7.59e-05	0.000748	CbGpPWpGaD
Tenofovir—Headache—Epirubicin—urinary bladder cancer	7.58e-05	0.000617	CcSEcCtD
Tenofovir—AK2—Metabolism—PPARG—urinary bladder cancer	7.58e-05	0.000748	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TYMS—urinary bladder cancer	7.42e-05	0.000732	CbGpPWpGaD
Tenofovir—Dizziness—Doxorubicin—urinary bladder cancer	7.41e-05	0.000602	CcSEcCtD
Tenofovir—NME2—Metabolism—GSTM1—urinary bladder cancer	7.33e-05	0.000723	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NCOR1—urinary bladder cancer	7.33e-05	0.000723	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CREBBP—urinary bladder cancer	7.29e-05	0.000718	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NQO1—urinary bladder cancer	7.25e-05	0.000715	CbGpPWpGaD
Tenofovir—Nausea—Epirubicin—urinary bladder cancer	7.19e-05	0.000585	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	7.16e-05	0.000706	CbGpPWpGaD
Tenofovir—Vomiting—Doxorubicin—urinary bladder cancer	7.12e-05	0.000579	CcSEcCtD
Tenofovir—Rash—Doxorubicin—urinary bladder cancer	7.06e-05	0.000574	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—urinary bladder cancer	7.06e-05	0.000574	CcSEcCtD
Tenofovir—NME2—Metabolism—GPX1—urinary bladder cancer	7.02e-05	0.000692	CbGpPWpGaD
Tenofovir—Headache—Doxorubicin—urinary bladder cancer	7.02e-05	0.00057	CcSEcCtD
Tenofovir—NME2—Metabolism—ERCC2—urinary bladder cancer	6.9e-05	0.00068	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.82e-05	0.000672	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	6.77e-05	0.000667	CbGpPWpGaD
Tenofovir—Nausea—Doxorubicin—urinary bladder cancer	6.65e-05	0.000541	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	6.58e-05	0.000649	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.54e-05	0.000644	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MTHFR—urinary bladder cancer	6.48e-05	0.000639	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	6.24e-05	0.000615	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	6.23e-05	0.000614	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	6.2e-05	0.000611	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTP1—urinary bladder cancer	6.05e-05	0.000596	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	6.05e-05	0.000596	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA2—urinary bladder cancer	6.04e-05	0.000595	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—urinary bladder cancer	5.97e-05	0.000588	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—urinary bladder cancer	5.93e-05	0.000584	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	5.83e-05	0.000575	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	5.78e-05	0.00057	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.69e-05	0.000561	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TYMS—urinary bladder cancer	5.62e-05	0.000554	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NCOR1—urinary bladder cancer	5.56e-05	0.000548	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTM1—urinary bladder cancer	5.56e-05	0.000548	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.51e-05	0.000543	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	5.45e-05	0.000537	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GPX1—urinary bladder cancer	5.32e-05	0.000525	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PPARG—urinary bladder cancer	5.26e-05	0.000518	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ERCC2—urinary bladder cancer	5.23e-05	0.000515	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—urinary bladder cancer	5.2e-05	0.000513	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	5.2e-05	0.000513	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	5.19e-05	0.000511	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	5.19e-05	0.000511	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CREBBP—urinary bladder cancer	5.05e-05	0.000498	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	5.04e-05	0.000497	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	5.04e-05	0.000497	CbGpPWpGaD
Tenofovir—AK2—Metabolism—EP300—urinary bladder cancer	4.96e-05	0.000489	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—urinary bladder cancer	4.91e-05	0.000484	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	4.54e-05	0.000448	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	4.52e-05	0.000446	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	4.5e-05	0.000444	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	4.42e-05	0.000436	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	4.42e-05	0.000436	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLAU—urinary bladder cancer	4.28e-05	0.000422	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	4.21e-05	0.000415	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	4.21e-05	0.000415	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	4.19e-05	0.000413	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	4.18e-05	0.000412	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—urinary bladder cancer	4.14e-05	0.000408	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.13e-05	0.000407	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPARG—urinary bladder cancer	3.98e-05	0.000393	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	3.85e-05	0.00038	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CREBBP—urinary bladder cancer	3.83e-05	0.000377	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.8e-05	0.000374	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—urinary bladder cancer	3.61e-05	0.000356	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	3.55e-05	0.00035	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CREBBP—urinary bladder cancer	3.53e-05	0.000348	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF1—urinary bladder cancer	3.49e-05	0.000344	CbGpPWpGaD
Tenofovir—NME2—Metabolism—EP300—urinary bladder cancer	3.44e-05	0.000339	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RHOA—urinary bladder cancer	3.2e-05	0.000315	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.19e-05	0.000314	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—urinary bladder cancer	3.13e-05	0.000309	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.06e-05	0.000302	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—urinary bladder cancer	2.73e-05	0.000269	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—urinary bladder cancer	2.68e-05	0.000264	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.66e-05	0.000262	CbGpPWpGaD
Tenofovir—NME1—Metabolism—EP300—urinary bladder cancer	2.61e-05	0.000257	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.58e-05	0.000254	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	2.57e-05	0.000253	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	2.43e-05	0.00024	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAT1—urinary bladder cancer	2.43e-05	0.00024	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EP300—urinary bladder cancer	2.41e-05	0.000237	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.39e-05	0.000236	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SRC—urinary bladder cancer	2.34e-05	0.000231	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	2.23e-05	0.000219	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2e-05	0.000198	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—urinary bladder cancer	1.94e-05	0.000191	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.89e-05	0.000187	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.84e-05	0.000182	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—urinary bladder cancer	1.72e-05	0.00017	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—urinary bladder cancer	1.65e-05	0.000162	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.48e-05	0.000146	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.47e-05	0.000145	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.42e-05	0.00014	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.33e-05	0.000131	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.15e-05	0.000113	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.07e-05	0.000105	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.07e-05	0.000105	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.06e-05	0.000104	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.03e-05	0.000102	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.02e-05	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NQO1—urinary bladder cancer	8.59e-06	8.47e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.34e-06	8.22e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.27e-06	7.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	7.17e-06	7.06e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.93e-06	6.84e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.66e-06	6.57e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.59e-06	6.49e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.59e-06	6.49e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPX1—urinary bladder cancer	6.31e-06	6.22e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	6.19e-06	6.1e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	5.82e-06	5.74e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.72e-06	4.65e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.53e-06	4.47e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.71e-06	3.66e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.24e-06	3.19e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.09e-06	3.04e-05	CbGpPWpGaD
